Literature DB >> 21211609

Electrical remodeling following percutaneous pulmonary valve implantation.

Carla M Plymen1, Aidan P Bolger, Philipp Lurz, Johannes Nordmeyer, Twin Yen Lee, Alamgir Kabir, Louise Coats, Seamus Cullen, Fiona Walker, John E Deanfield, Andrew M Taylor, Philipp Bonhoeffer, Pier D Lambiase.   

Abstract

Sudden cardiac death in congenital heart disease is related to increased right ventricular end-diastolic volume (RVEDV), abnormalities of QRS duration, and QRS, JT, and QT dispersions. Surgical pulmonary valve replacement and percutaneous pulmonary valve implantation (PPVI) decrease RVEDV, but the effects of PPVI on surface electrocardiographic parameters are unknown. PPVI represents a pure model of RV mechanical and electrophysiologic changes after replacement. This prospective study sought to determine the effects of PPVI on surface electrocardiographic parameters: Ninety-nine PPVI procedures in patients with congenital heart disease (23.1 ± 10 years of age) were studied before, after, and 1 year after PPVI with serial electrocardiograms and echocardiogram/magnetic resonance images. Forty-three percent had pulmonary stenosis, 27% pulmonary regurgitation (PR), and 29% mixed lesions. In those with predominantly PR (n = 26), QRS duration decreased significantly (135 ± 27 to 128 ± 29 ms, p = 0.007). However, in the total cohort no significant change in QRS duration at 1 year was observed (137 ± 29 to 134 ± 29 ms). Corrected QT interval and QRS, QT, and JT dispersions significantly decreased at 1 year (p ≤0.001). RVEDV correlated with preprocedure QRS duration (r = 0.34, p <0.002) but there was no correlation after PPVI. In conclusion, this is the first study reporting electrical remodeling after isolated PPVI and it confirms that decreases in QRS duration occur after PPVI in PR, as reported for equivalent surgical cohorts. Further, increased homogeneity of repolarization in combination with improved conduction may decrease arrhythmic events in congenital cardiac patients with pulmonary valvular disease. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21211609     DOI: 10.1016/j.amjcard.2010.09.017

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  Clinical issues and outcomes in adults following repair of tetralogy of fallot.

Authors:  Bejal Pandya; Michael A Quail; Seamus Cullen
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-10

Review 2.  Pulmonic Valve Disease: Review of Pathology and Current Treatment Options.

Authors:  Mouhammad Fathallah; Richard A Krasuski
Journal:  Curr Cardiol Rep       Date:  2017-09-16       Impact factor: 2.931

Review 3.  Valvular heart disease in congenital heart disease: a narrative review.

Authors:  Joshua M Saef; Joanna Ghobrial
Journal:  Cardiovasc Diagn Ther       Date:  2021-06

Review 4.  Percutaneous Pulmonary Valve Implantation: Current Status and Future Perspectives.

Authors:  Bart W Driesen; Evangeline G Warmerdam; Gert-Jan Sieswerda; Folkert J Meijboom; Mirella M C Molenschot; Pieter A Doevendans; Gregor J Krings; Arie P J van Dijk; Michiel Voskuil
Journal:  Curr Cardiol Rev       Date:  2019

5.  Ventricular Arrhythmias and Sudden Death Following Percutaneous Pulmonary Valve Implantation in Pediatric Patients.

Authors:  Pierre-Olivier Veillette; Joaquim Miro; Paul Khairy; Sylvia Abadir; Mathieu Le Bloa
Journal:  Pediatr Cardiol       Date:  2022-04-08       Impact factor: 1.838

Review 6.  Percutaneous pulmonary valve implantation.

Authors:  Hussam S Suradi; Ziyad M Hijazi
Journal:  Glob Cardiol Sci Pract       Date:  2015-09-08

7.  Percutaneous Pulmonary Valve Implantation Alters Electrophysiologic Substrate.

Authors:  Hoang H Nguyen; Shabana Shahanavaz; George F Van Hare; David T Balzer; Ramzi Nicolas; Jennifer N Avari Silva
Journal:  J Am Heart Assoc       Date:  2016-09-30       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.